Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Esophageal squamous carcinoma

JMJD2A JMJD2C is amplified in esophageal squamous carcinomas and in desmoblastic JMJD2B medulloblastomas. [Pg.273]

Several black tea derived polyphenols, including theaflavin-3,3 -digallate, can inhibit in vitro the growth of human esophageal squamous carcinoma cells at concentrations near 20 and theaflavin monogallates have in vitro inhibited growth of human colon cancer... [Pg.340]

Ozawa S, Ueda M, Ando N, Kitagawa Y, Kitajima M. 2001. Antiproliferative effects ofZD1839 ( Iressa ) on esophageal squamous carcinoma cells. Proc. Am. Assoc. Cancer Res. 42 8 (Abstr.)... [Pg.221]

Distinction between SCC and thymic carcinoma is also occasionally required. CD5 can be diffusely and strongly positive in primary thymic carcinoma and nonreactive in esophageal SCCs. Importantly, selective CD5 reactivity of thymic carcinomas is highly dependent on the pTI of the antigen retrieval solution and the antibody clone. Some CD5 antibodies diffusely and strongly stain both thymic carcinomas and esophageal squamous carcinomas. 79... [Pg.503]

The possible modes of action of 4HPR have been mostly investigated in already transformed tumor cells. 4HPR suppressed the proliferation of cell lines of different tumor types such as human breast carcinoma [24-27], prostate adenocarcinoma [28, 29], leukemias [30, 31], neuroblastoma [32, 33, 34], ovarian carcinoma [35, 36], cervical carcinoma [37, 38], head and neck squamous cell carcinoma [39], esophageal squamous carcinoma [40] and small-cell lung can-... [Pg.242]

Muller A, Nakagawa H, Rustgi AK (1997) Retinoic acid and N-(4-hydroxy-phenyl)retinamide suppress growth of esophageal squamous carcinoma cell lines. Cancer Lett 113 95-101... [Pg.249]

LRP1B Loss-of-function (sporadic) Esophageal squamous cell carcinoma, nonsmall-cell lung cancer... [Pg.706]

Ding Y, Shimada Y, Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 2003 9 3406-3412. [Pg.347]

Franklin R, Steiger Z, Vaishampayan G, et al. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983 51(6) 1062-1071. [Pg.233]

Y.C. Yoon, K.S. Lee, Y.M. Shim, B.T. Kim, K. Kim, T.S. Kim, Metastasis to regional lymph nodes In patients with esophageal squamous cell carcinoma CT versus FDG PET for presurgical detection prospective study. Radiology 227(3) (2003) 764-770. [Pg.186]

H.A. Wieder, B.L. Brucher, F. Zimmermann, K. Becker, F. Lordick, A. Beer, M. Schwaiger, U. Fink, J.R. Siewert, H.J. Stein, W.A. Weber, Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment, J. Clin. Oncol. 22(5) (2004) 900-908. [Pg.187]

Zhang L, Ymg W, Mao Y et al. Loss of clusterin both in serum and tissue correlates with the tumori-genesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 2003 9 650-654. [Pg.44]

Fujita Y, Nakanishi T, Fliramatsu M et al. Proteomics-based approach identifying auto-antibody against peroxiredoxin Vt as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 2006 12 6415-6420. [Pg.44]

FIGURE 14.2 Cytokeratin reactivity in esophageal squamous cell carcinoma. [Pg.503]

CDS, if performed correctly, can be used to distinguish thymic carcinoma from esophageal squamous cell carcinoma. [Pg.503]

Amatya VJ, Takeshima Y, Kaneko M, Inai K. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation. Pathol Int. 2004 54 803-809. [Pg.532]

Ohta, M., Kitadai, Y.,et al. (2002). Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 102(3) 220 4. [Pg.27]

CCR7 expression was positively correlated with regional LN metastasis in T1 breast cancer [21], cervical cancer [22], melanoma [23], colorectal carcinoma [24], gastric carcinoma [25, 26], oral and oropharyngeal squamous cell carcinoma [27], squamous cell carcinoma of tonsil [28], esophageal squamous cell carcinoma [29], squamous cell carcinoma of the head and neck (SCCHN) [30], thyroid carcinoma [31], nonsmall cell lung cancer [32], hepatocellular cancer [33], prostate cancer [34], adult T-cell leukemia [35], and chronic lymphocytic leukemia [36, 37]. [Pg.96]

See other pages where Esophageal squamous carcinoma is mentioned: [Pg.340]    [Pg.37]    [Pg.280]    [Pg.776]    [Pg.383]    [Pg.242]    [Pg.340]    [Pg.37]    [Pg.280]    [Pg.776]    [Pg.383]    [Pg.242]    [Pg.261]    [Pg.174]    [Pg.116]    [Pg.17]    [Pg.23]    [Pg.24]    [Pg.27]    [Pg.186]    [Pg.160]    [Pg.23]    [Pg.208]    [Pg.502]    [Pg.503]    [Pg.503]    [Pg.97]    [Pg.87]    [Pg.102]    [Pg.141]    [Pg.465]    [Pg.262]   
See also in sourсe #XX -- [ Pg.340 ]



SEARCH



Carcinoma esophageal

Carcinoma esophageal squamous cell

Esophageal

Esophagitis

Squamous

Squamous carcinomas

© 2024 chempedia.info